Clinical TopicsEndocrinologyWeb Exclusives

Early, intensive therapy for type 2 diabetes can slow progression


A study of 58 patients with type 2 diabetes found that early and intensive therapy helped preserve beta cell function for 3.5 years. In the study, published in Diabetes Care, patients with newly diagnosed type 2 diabetes received insulin and metformin for 3 months, then were randomly assigned to one of two groups: 1) insulin plus metformin and 2) triple oral therapy (metformin, glyburide, and pioglitazone). Read more.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.


Recent Posts